Health Canada
Symbol of the Government of Canada
Consumer Product Safety

Incident Report

Subform I: General Information

1. Report Type.

New incident report

Incident Report Number: 2012-0720

2. Registrant Information.

Registrant Reference Number: 12022011-JGTF

Registrant Name (Full Legal Name no abbreviations): Joint Glyphosate Task Force, LLC

Address: 8325 Old Deer Trail

City: Raleigh

Prov / State: NC

Country: USA

Postal Code: 27615

3. Select the appropriate subform(s) for the incident.

Scientific Study

4. Date registrant was first informed of the incident.

5. Location of incident.

6. Date incident was first observed.

Product Description

7. a) Provide the active ingredient and, if available, the registration number and product name (include all tank mixes). If the product is not registered provide a submission number.

Active(s)

PMRA Registration No.       PMRA Submission No. 2004-0175      EPA Registration No.

Product Name: MON 2139

  • Active Ingredient(s)
    • GLYPHOSATE (PRESENT AS ISOPROPYLAMINE SALT OR ETHANOLAMINE SALT)

7. b) Type of formulation.

Application Information

8. Product was applied?

Unknown

9. Application Rate.

10. Site pesticide was applied to (select all that apply).

11. Provide any additional information regarding application (how it was applied, amount applied, the size of the area treated etc).

To be determined by Registrant

12. In your opinion, was the product used according to the label instructions?

Unknown

Subform VII: Scientific Study

1. Study Reference

Title Acute Toxicity Test (Embryo-Larval) with Eastern Oyster (Crassostrea virginica) Under Static Conditions

Date 13-JAN-12

2. a) Is an extension needed to translate the document?

No

3. Type of incident identified in the study

Presence of a component or derivitive

4. Describe the incident identified in the study (e.g. study demonstrates an increased risk to non-Hodgkin's Lymphoma after exposure to pesticide X)

We believe these are the first of these guideline studies to be conducted with the MON 2139 formulation. Although the LC50 and EC50 obtained for these studies are of the same magnitude as those existing for freshwater species and the results may not specifically meet FIFRA 6(a)(2) criteria for adverse effects, we are providing these saltwater species results to the Agency as new information. These results are not expected to meaningfully change the risk assessment for aquatic animals given that the LC50/EC50 values are close to values that have been previously reported.

5. a) Was the study discontinued before completion?

No

5. b) Provide the reason for discontinuation

6. If the study is ongoing, what is the expected completion date?

13-JAN-12

For Registrant use only

7. Provide supplemental information here